Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Agoulnik · SciRah

Researcher profile · Semantic Scholar

S. Agoulnik

Share profile

S. Agoulnik — researcher profile on SciRah

h-index: 14
Works: 25
Citations: 1,273

Most-cited papers

Circulating miRNA Biomarkers for Alzheimer's Disease
Pavan Kumar, Z. Dezső, C. Mackenzie, J. Oestreicher +9 more
2013PLoS ONE371 citations Open access
Semantic Scholar
Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial–mesenchymal transition (EMT) to mesenchymal–epithelial transition (MET) states
Taku Yoshida, Y. Ozawa, Takayuki Kimura, Yoshiaki Sato +7 more
2014British Journal of Cancer339 citations Open access
Semantic Scholar
Potent in vitro and in vivo anticancer activities of des-methyl, des-amino pateamine A, a synthetic analogue of marine natural product pateamine A
G. Kuznetsov, Qunli Xu, L. Rudolph-Owen, Karen Tendyke +16 more
2009Molecular Cancer Therapeutics101 citations Open access
Semantic Scholar
Discovery of Selective Estrogen Receptor Covalent Antagonists for the Treatment of ERαWT and ERαMUT Breast Cancer.
X. Puyang, Craig Furman, Guo-Zhu Zheng, Z. Wu +49 more
2018Cancer Discovery80 citations Open access
Semantic Scholar
Apratoxin A Shows Novel Pancreas-Targeting Activity through the Binding of Sec 61
Kuan-Chun Huang, Zhi-Hong Chen, Yi-Min Jiang, Sandeep Akare +15 more
2016Molecular Cancer Therapeutics70 citations
Semantic Scholar
Gene Expression Profiling Reveals Epithelial Mesenchymal Transition (EMT) Genes Can Selectively Differentiate Eribulin Sensitive Breast Cancer Cells
Z. Dezső, J. Oestreicher, Amy A. Weaver, Stephanie Santiago +4 more
2014PLoS ONE62 citations Open access
Semantic Scholar
Phase II study of eribulin mesylate (E7389) in patients with metastatic castration-resistant prostate cancer stratified by prior taxane therapy.
J. de Bono, L. Molife, G. Sonpavde, J. Maroto +9 more
2012Annals of Oncology55 citations Open access
Semantic Scholar
Correlative Analyses of Patient and Clinical Characteristics Associated with Efficacy in Tisagenlecleucel-Treated Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients in the Juliet Trial
J. Westin, C. Tam, P. Borchmann, U. Jaeger +27 more
2019Blood37 citations Open access
Semantic Scholar
Eribulin mesylate exerts specific gene expression changes in pericytes and shortens pericyte-driven capillary network in vitro
S. Agoulnik, S. Kawano, Noel Taylor, J. Oestreicher +4 more
2014Vascular Cell37 citations Open access
Semantic Scholar
An updated analysis of JULIET, a global pivotal phase 2 trial of tisagenlecleucel in adult patients with relapsed or refractory (r/r) diffuse large B-cell lymphoma (DLBCL)
P. Borchmann, C. Tam, U. Jaeger, J. McGuirk +19 more
201832 citations
Semantic Scholar
Gene Expression Analyses Support Fallopian Tube Epithelium as the Cell of Origin of Epithelial Ovarian Cancer
D. O'shannessy, Stephen M. Jackson, N. Twine, B. E. Hoffman +3 more
2013International Journal of Molecular Sciences31 citations Open access
Semantic Scholar
Sensitivity to halichondrin analog E7389 and hemiasterlin analog E7974 correlates with {beta}III tubulin isotype expression in human breast cancer cell lines
S. Agoulnik, G. Kuznetsov, Karen Tendyke, L. Parent +5 more
200520 citations
Semantic Scholar
Phase II study of eribulin mesylate (E7389) in patients with metastatic castration-resistant prostate cancer stratified by prior taxane therapy.
J. de Bono, L. Molife, G. Sonpavde, J. Maroto +9 more
201215 citations Open access
Semantic Scholar
Discovery of Selective Estrogen Receptor Covalent Antagonists for the Treatment of ER alphaWTand ER alphaMUTBreast Cancer.
X. Puyang, Craig Furman, Guo-Zhu Zheng, Z.-J. Wu +49 more
201814 citations
Semantic Scholar
Abstract #3687: In vivo anticancer activity of E6201, a novel MEK1 inhibitor, against BRAF-mutated human cancer xenografts
Jiayi Wu, K. Nomoto, John Q. Wang, G. Kuznetsov +7 more
20093 citations
Semantic Scholar
Correlative Analyses of Cytokine Release Syndrome and Neurological Events in Tisagenlecleucel-Treated Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients
V. Bachanova, J. Westin, C. Tam, P. Borchmann +26 more
2019Clinical Lymphoma, Myeloma & Leukemia2 citations
Semantic Scholar
Abstract 3830: Eribulin and Paclitaxel differentially affect gene expression profiling of blood vessel cells and in vitro angiogenesis in co-cultures of human endothelial cells with pericytes.
S. Agoulnik, J. Oestreicher, Noel Taylor, Mai Uesugi +7 more
20132 citations
Semantic Scholar
Abstract 1522: Gene expression profiling (GEP) reveals Epithelial Mesenchymal Transition (EMT) genes selectively differentiating eribulin sensitive breast cancer cell lines.
Z. Dezső, J. Oestreicher, Amy A. Weaver, T. Kadowaki +4 more
20132 citations
Semantic Scholar
Abstract 3266: Antitumor activity of a combination of lenvatinib mesilate, ifosfamide, and etoposide against human pediatric osteosarcoma cell lines
M. Matsuki, Kiyoshi Okamoto, Z. Dezső, S. Agoulnik +2 more
20161 citations
Semantic Scholar
Abstract 1371: Systems biology analysis to identify biomarkers for lenvatinib in the preclinical cancer cell line panels
Z. Dezső, M. Ino, Y. Minoshima, O. Tohyama +4 more
20151 citations
Semantic Scholar
Abstract P5-06-03: Combination of the PARP inhibitor E7449 with eribulin +/- carboplatin in preclinical models of triple negative breast cancer
S. McGonigle, Jiayi Wu, D. Kolber-Simonds, N. Twine +10 more
20151 citations
Semantic Scholar
P-Selectin Blockage Potentiates the Inhibiting Effects of Inflammasome Cytokine Neutralization on Leukocyte Recruitment in an In Vivo Model of Acute Sickle Cell Vaso-Occlusion
E. Gotardo, L. Torres, L. F. Gushiken, Pâmela L. Brito +9 more
2022Blood0 citations
Semantic Scholar
Abstract P1-10-08: Development of a first-in-class oral selective ERα covalent antagonist (SERCA) for the treatment of ERαWT and ERαMUT breast cancer
M. Korpal, X. Puyang, Craig Furman, Zheng-Guo Zhu +44 more
20180 citations
Semantic Scholar
Abstract 3258: Gene expression and mutation analysis in human osteosarcoma xenograft models associated with combination activity of lenvatinib with etoposide and ifosfamide
Z. Dezső, S. Agoulnik, C. Mackenzie, K. Mitsuhashi +3 more
20160 citations
Semantic Scholar
Abstract 899: Characterization and establishment of a drug-resistant human lung cancer model.
Kuan-Chun Huang, J. Oestreicher, N. Twine, Winnie Lee +5 more
20130 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Z. Dezső×8
Invite
Z. Dezső — researcher profile on SciRah
G. Kuznetsov×8
Invite
G. Kuznetsov — researcher profile on SciRah
Y. Funahashi×8
Invite
Y. Funahashi — researcher profile on SciRah
J. Oestreicher×6
Invite
J. Oestreicher — researcher profile on SciRah

×6

Invite

J. Matsui — researcher profile on SciRah

C. Mackenzie×5

Invite

C. Mackenzie — researcher profile on SciRah

Invite

N. Twine — researcher profile on SciRah

Invite

Y. Oda — researcher profile on SciRah

Invite

Noel Taylor — researcher profile on SciRah

B. Littlefield×4

Invite

B. Littlefield — researcher profile on SciRah

Invite

K. Nomoto — researcher profile on SciRah

Karen Tendyke×3

Invite

Karen Tendyke — researcher profile on SciRah